Volatilomic response to targeted cancer therapy in vitro

Abstract Clinical advancement of novel therapeutics is often hindered by variable patient responses. Therefore, clinically translatable biomarkers of response are urgently required to facilitate precision medicine trials. Endogenous volatile organic compounds (VOCs) can be non-invasively detected in...

Full description

Saved in:
Bibliographic Details
Main Authors: Philip K. H. Leung, Innah Kim, Bibek Das, George B. Hanna
Format: Article
Language:English
Published: Nature Portfolio 2025-06-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-04886-5
Tags: Add Tag
No Tags, Be the first to tag this record!